Effect of XXXX on International Prostate Symptom Score and prostate volume.

@entity1 @entity1486 @entity28
AIM: The aim of this study was to investigate the relationship between @entity28 and lower urinary tract symptoms and prostate volume in @entity1 who underwent prostate biopsies. MATERIALS AND METHODS: Between December 2008 and November 2009, transrectal ultrasound-guided prostate biopsy was performed on @entity1 who had elevated @entity1486 levels or abnormal digital rectal examination findings. A total of 211 @entity1 were included in this study. Prostate volumes, International Prostate Symptom Score (IPSS) values, and the @entity1 's height and weight were all recorded during the biopsy. Body mass index (BMI) <18.5 was determined as underweight, 18.5-23.0 normal, 23.0-27.5 overweight, and >27.5 @entity28 . RESULTS: The mean age of the @entity1 was 68.0    6.3 years, and the mean BMI was 28.0    4.9 kg/m(2). The mean prostate volume of the normal, overweight, and @entity28 groups was 30, 50, and 70 ml, respectively. The positive and statistically significant correlation between BMI and prostate volume was determined (P < 0.001). According to BMI, the mean IPSS was 8.0, 16.5, and 20.0 in the groups, respectively. Similarly, a statistically positive correlation between BMI and IPSS was demonstrated (P < 0.001). CONCLUSIONS: As the result of a rise in BMI, prostate volumes and IPSS increase in @entity1 . Prostate volume and IPSS decrease due to weight loss, and hence that fewer urinary symptoms occur, and the quality-of-life of @entity1 may increase.
